Roll-up CDD validates two theses, not one
On a standalone business, CDD is about the company in its market. Roll-up CDD has to answer two questions, and they are not the same question.
- Is the platform itself defensible? The standard commercial thesis. Why customers buy, how the platform wins versus alternatives, how the unit economics actually work, what would have to be true post-close.
- Is the underlying market structurally rollable? Different question. Are there enough operators of the right size, in the right geographies, with sufficient density to fund add-on growth and realize the synergies the model assumes.
We see roll-up theses fail at (2) all the time. The platform looks fine. The market does not actually roll.
What rollability means
A market is rollable when four conditions hold.
- Real fragmentation. Not just a long tail. Enough operators in the $1M–$15M revenue band, in the geographies the platform cares about, to source meaningful add-ons for years.
- Density advantage. The platform actually benefits from co-locating routes or sites within an MSA. A national footprint built from one-of-each in 50 cities is usually worse than a deep footprint in 10 MSAs.
- Synergy realism. The synergies the model assumes (back-office consolidation, procurement, cross-selling, route density) are achievable at the headcount and integration intensity the sponsor will fund.
- Labor and regulatory headroom. The labor pool supports growth at the assumed wage curve. Regulation does not punish scale in ways the model misses (licensing, reimbursement, franchise law).
How we size the market at the MSA level
National TAM is a vanity number for a roll-up. The platform does not grow nationally. It grows location by location, MSA by MSA. The TAM that matters is the TAM in the MSAs the platform operates in plus the MSAs it can realistically expand into.
At 2nd St Strategy, every roll-up CDD starts at the MSA level. We use our own software platform, PinpointIQ, which covers 900+ U.S. metropolitan statistical areas across 30+ location-based and route-based verticals. For each MSA in the platform’s footprint (and each candidate expansion market), we produce:
- Total addressable market, decomposed by segment and demographic driver.
- Competitive density: deduplicated operator counts with revenue, employee, and year-founded data where available.
- Demographic drivers at the census-tract level relevant to the vertical (household formation, age bands, household income, etc.).
- White-space maps highlighting under-served census tracts inside each MSA.
That gives the deal team an objective starting read on rollability. The qualitative work tests whether the on-the-ground reality matches the data.
What we look for in the qualitative work
Customer interviews on roll-ups are different from standalone CDD. The question is not just “why do you buy this brand.” It is also “do you experience this category as branded at all, or as commoditized.”
- Brand sensitivity by segment. In some categories, customers actively prefer national brands (pest control, certain HVAC). In others, brand is invisible and the local relationship is the asset (funeral, dental, vet). The right answer changes the synergy story.
- Operator interviews. Talking to owners of add-on-sized businesses in the category. Why would they sell, at what multiples, to whom. What changes when a PE-backed roll-up shows up in their MSA.
- Former integration leads. What it actually costs and takes to integrate an add-on in this category. The model and the reality often differ by a factor of two on time, and the difference compounds.
What kills a roll-up thesis in diligence
Three patterns show up repeatedly.
- Fragmented but not rollable. Plenty of operators but they are too small, too geographically dispersed, or the customer does not care which brand shows up. Density does not buy anything.
- Synergies relied on growth that did not happen. Historical add-ons under the current platform did not actually realize the cost or revenue synergies the model assumes for new add-ons.
- Labor or regulation breaks the curve. The wage curve, the licensing burden, or the reimbursement environment punishes scale in ways the spreadsheet does not capture.
When to bring 2nd St in
Earlier than most sponsors do. We do a lot of pre-LOI screening on roll-up theses where the question is “is this market actually rollable, before we go firm.” The combination of qualitative depth and PinpointIQ’s MSA-level data lets us call that directionally in two weeks.
